Donna A. Volpe Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences Center for Drug Evaluation and Research, Food and Drug Administration Biography Publications Institution JoVE Articles Donna A. Volpe has not added a biography. If you are Donna A. Volpe and would like to personalize this page please email our Author Liaison for assistance. Publications Characterization of a Commercially Available Line of IPSC Hepatocytes As Models of Hepatocyte Function and Toxicity for Regulatory Purposes Journal of Pharmacological and Toxicological Methods. Jul-Aug, 2021 | Pubmed ID: 34098110 Methadone Metabolism and Drug-Drug Interactions: In Vitro and In Vivo Literature Review Journal of Pharmaceutical Sciences. 12, 2018 | Pubmed ID: 30205091 In Vitro UGT1A1 Inhibition by Tyrosine Kinase Inhibitors and Association with Drug-induced Hyperbilirubinemia Cancer Chemotherapy and Pharmacology. 11, 2018 | Pubmed ID: 30105461 Use of Different Parameters and Equations for Calculation of IC₅₀ Values in Efflux Assays: Potential Sources of Variability in IC₅₀ Determination The AAPS Journal. Jan, 2014 | Pubmed ID: 24338112 Effect of Uremic Serum and Uremic Toxins on Drug Metabolism in Human Microsomes Regulatory Toxicology and Pharmacology : RTP. Mar, 2014 | Pubmed ID: 24184159 Drug-permeability and Transporter Assays in Caco-2 and MDCK Cell Lines Future Medicinal Chemistry. Dec, 2011 | Pubmed ID: 22098353 Uniform Assessment and Ranking of Opioid μ Receptor Binding Constants for Selected Opioid Drugs Regulatory Toxicology and Pharmacology : RTP. Apr, 2011 | Pubmed ID: 21215785 Application of Method Suitability for Drug Permeability Classification The AAPS Journal. Dec, 2010 | Pubmed ID: 20811966 Effect of Altered Temperature Storage on the in Vitro Cellular Uptake of Liposome Drug Products Journal of Liposome Research. Jun, 2010 | Pubmed ID: 19848447 Effect of Ethanol on Opioid Drug Permeability Through Caco-2 Cell Monolayers The AAPS Journal. Jun, 2008 | Pubmed ID: 18592381 Variability in Caco-2 and MDCK Cell-based Intestinal Permeability Assays Journal of Pharmaceutical Sciences. Feb, 2008 | Pubmed ID: 17542022 Hundens tarmorganoider i ett permeabelt stödsystem med dubbla kammare Vojtech Gabriel1, Christopher Zdyrski1, Dipak K. Sahoo2, Kimberly Dao3, Agnes Bourgois-Mochel2, Todd Atherly3, Marilyn N. Martinez4, Donna A. Volpe5, Jamie Kopper2, Karin Allenspach2,3, Jonathan P. Mochel1,3 1Department of Biomedical Sciences, College of Veterinary Medicine, Iowa State University, 2Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Iowa State University, 33D Health Solutions Inc., 4Office of New Animal Drug Evaluation, Center for Veterinary Medicine, Food and Drug Administration, 5Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration JoVE 63612 Imunologia e Infecção
Hundens tarmorganoider i ett permeabelt stödsystem med dubbla kammare Vojtech Gabriel1, Christopher Zdyrski1, Dipak K. Sahoo2, Kimberly Dao3, Agnes Bourgois-Mochel2, Todd Atherly3, Marilyn N. Martinez4, Donna A. Volpe5, Jamie Kopper2, Karin Allenspach2,3, Jonathan P. Mochel1,3 1Department of Biomedical Sciences, College of Veterinary Medicine, Iowa State University, 2Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Iowa State University, 33D Health Solutions Inc., 4Office of New Animal Drug Evaluation, Center for Veterinary Medicine, Food and Drug Administration, 5Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration JoVE 63612 Imunologia e Infecção